Development and Main Stages of Introduction of the Preparation “Cholera O139 Diagnostic Fluorescent Immunoglobulins”
https://doi.org/10.21055/0370-1069-2012-3-74-78
Abstract
– for environmental objects. Application of the preparation for practical purposes was considered to be promising, and it was recommended for State registration as a product of medical application.
About the Authors
T. V. Alenkina
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
G. V. Bochkareva
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
L. V. Sayapina
Research Center for Evaluation of Products for Medical Application
Russian Federation
Russian Federation
I. V. Kasina
Research Center for Evaluation of Products for Medical Application
Russian Federation
Russian Federation
I. V. Shul’Gina
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
O. A. Lobovikova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
E. G. Abramova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
O. V. Gromova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
A. K. Nikiforov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
References
1. Alekseeva L.P., Mazrukho B.L., Markina O.V. et al. [Obtaining of monoclonal fluorescent diagnostic immunoglobulins for Vibrio cholerae O139]. Clin. Lab. Diagn. 2002; 12:50–1.
2. Alekseeva L.P., Sal’nikova O.I., Mazrukho B.L., Markina O.V., Chemisova O.S., Lobanov V.V. [Monoclonal antibodies for Vibrio cholerae O139 lipopolisaccharide]. Biotekhnologya. 2002; 2:79–84.
3. Goldin R.B., Beletskaya L.V., Kryukova I.N. et al. [Immunoluminescence in Medicine]. M.; 1977. 240 p.
4. Gromova O.V., Dzhaparidze M.N., Dyatlov I.A., Eliseev Yu.Yu., Kireev M.N., Kosmoenko O.L. [Method of obtaining of cholera purified O-antigen]. RF Patent 2143280.
5. Lomov Yu.M. [Cholera agent evolution and prognosis on this infec- tion for the nearest future]. Epidemiol. Infek. Bol. 2004; 1:7–12.
6. Onishchenko G.G., Ganin V.S., Golubinsky E.P. [Non-O1 Vibrios and Their Impact in Human Pathology]. M.; 2001. 384 p.
7. Onishchenko G.G., Kutyrev V.V., editors. [Laboratory Diagnostics of Dangerous Infectious Diseases]. M.; 2009. 472 p.
8. Smirnov V.V., Chaplinsky V.Ya., Andreeva Z.M. et al. [Scientific Bases of Diagnostic Preparations Production]. Kiev; 1980. 195 p.
9. Smirnova N.I. [Cholera agent of the new O139 serogroup: molecular genetic peculiarities and origin]. Mol. Gen. Mikrobiol. Virusol. 2002; 3:23– 33.
10. Fedorova V.A., Gromova O.V., Devdariani Z.L. [Immuno-enzyme test-system for Vibrio cholerae O139 detection]. Zh. Mikrobiol. Epidemiol. Immunobiol. 1998; 5:77–80.
11. Yarovaya L.M., Aleshkin V.A. [New data on chemical structure of lipopolysaccharides and practical prospects]. Zh. Mikrobiol. Epidemiol. Immunobiol. 1991; 3:73–8.
Review
For citations:
Alenkina T.V., Bochkareva G.V., Sayapina L.V., Kasina I.V., Shul’Gina I.V., Lobovikova O.A., Abramova E.G., Gromova O.V., Nikiforov A.K. Development and Main Stages of Introduction of the Preparation “Cholera O139 Diagnostic Fluorescent Immunoglobulins”. Problems of Particularly Dangerous Infections. 2012;(3(113)):74-78. (In Russ.) https://doi.org/10.21055/0370-1069-2012-3-74-78
Views:
539
Email this article 